MedTrace Logo

Cardiorespiratory Diagnostic Study

NCT04939558 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 744

Last updated 2023-06-02

No results posted yet for this study

Summary

This study uses a new breathing device called 'N-Tidal C' handset which measures breathing patterns. Investigators have found that people with cardiac and respiratory illnesses breathe out a gas, called carbon dioxide (CO2), in a different way to healthy people. The pattern of breathed out CO2 (the waveform) varies according to the underlying health of the user's lungs. Monitoring these changes may help doctors to more accurately diagnose and monitor the most common and serious respiratory conditions.

Conditions

Interventions

DEVICE

N-Tidal C handset

Participants are to use the 'N-Tidal C' handset every day for 14 days. This will ideally be two times a day (once in the morning and once in the evening, before using any regular inhalers). Each breath record requires the participant to breathe through the mouthpiece for 75 seconds in a relaxed manner.

Sponsors & Collaborators

  • Innovate UK

    collaborator OTHER_GOV

  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV

  • TidalSense

    lead INDUSTRY

Principal Investigators

  • Zishan Ali, MBBS BSc · Modality Partnership

  • Elango Vijaykumar, MBBS, FRCG · Modality Partnership

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-02
Primary Completion
2022-11-02
Completion
2022-11-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04939558 on ClinicalTrials.gov